PCA
GSK icon

Personal Capital Advisors’s GSK GSK Stock Holding History

Personal Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$242K Sell
6,873
-69
-1% -$2.3K ﹤0.01% 422
2022
Q3 		$204K Buy
6,942
+982
+16% +$37.2K ﹤0.01% 434
2022
Q2 		$324K Buy
5,960
+4
+0.1% +$221 ﹤0.01% 335
2022
Q1 		$324K Sell
5,956
-474
-7% -$25.7K ﹤0.01% 372
2021
Q4 		$354K Buy
+6,430
New +$334K ﹤0.01% 405

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Personal Capital Advisors's GSK Position: Q4 2022 in Review

Personal Capital Advisors reduced its GSK (GSK) stake by 0.99% in Q4 2022, selling an estimated $2.3K and leaving 6,873 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Personal Capital Advisors first reported a position in GSK in Q4 2021 and has held it in 5 quarters since. The position peaked at $354K in Q4 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Personal Capital Advisors held 6,873 shares of GSK worth $242K as of Q4 2022.
  • Personal Capital Advisors sold 69 GSK shares in Q4 2022, an estimated $2.3K.
  • GSK made up ﹤0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #422 holding.
  • Personal Capital Advisors first reported a position in GSK in Q4 2021 and has held it in 5 quarters since.
  • Personal Capital Advisors's GSK position peaked at $354K in Q4 2021.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.